- ►ahajournals.org K Esposito, D Giugliano, F Nappo, R Marfella … - Circulation, 2004 - Am Heart Assoc Methods and Results— We performed a randomized, single-blind trial on 175
drug-naive patients with type 2 diabetes mellitus (93 men and 82 women), 35 to
70 years of age, selected from a population of 401 patients who ... Cited by 148 - Related articles - BL Direct - All 7 versions
- ►adisonline.com [PDF] M Rendell - Drugs, 2004 - ingentaconnect.com The sulphonylureas act by triggering insulin release from the pancreatic β
cell. Abstract A specific site on the adenosine triphosphate (ATP)-sensitive
potassium channels is occupied by sulphonylureas leading to closure of the ... Cited by 86 - Related articles - BL Direct - All 7 versions
- ►nih.gov MT Sheehan - Clinical Medicine & Research, 2003 - Marshfield Clinic The incidence of type 2 diabetes mellitus (DM) in the United States continues to
grow rapidly, paralleling the overweight and obesity epidemic. For many years
the only therapeutic options for type 2 DM were sulfonylureas and insulin. ... Cited by 43 - Related articles - All 9 versions
JF Blickle - Diabetes and Metabolism, 2006 - Elsevier Glinides represent a chemically heterogeneous new class of insulinsecreting
agents characterized by a rapid onset and short duration of action. They act by
closure of the ATP-dependant K channel. Repaglinide, the only glinide ... Cited by 16 - Related articles - BL Direct - All 3 versions
J Li, H Tian, Q Li, N Wang, T Wu, Y Liu, Z Ni, … - Diabetes Obes Metab, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 8 - Related articles - All 5 versions
M Yngen, CG Ostenson, P Hjemdahl, NH … - Diabetic Medicine, 2006 - interscience.wiley.com Methods Fifteen patients with Type 2 diabetes were investigated on three
occasions: at baseline without oral hypoglycaemic drug treatment, and after 6
weeks' treatment with repaglinide or glibenclamide, respectively, in an ... Cited by 8 - Related articles - BL Direct - All 4 versions
- Free from Publisher LS Cozma, SD Luzio, GJ Dunseath, PM … - Diabetes care, 2005 - Am Diabetes Assoc RESULTS—The insulinogenic index (ΔI30/ΔG30) and insulin area under the curve
(AUC) from 0 to 30 min (AUC 0–30 ) were higher with the 4-mg drug dose
compared with the two lower doses and with 2 mg compared with 0.5 mg. On ... Cited by 7 - Related articles - All 5 versions
BL Wajchenberg - Arquivos Brasileiros de Endocrinologia & Metabologia, 2007 - SciELO Brasil This article reviews the role of fasting and postprandial glycemia to the
overall glycemic control of patients with type 2 diabetes and glucose
intolerance, as well as their causal relationship upon micro and ... Cited by 5 - Related articles - Cached - All 5 versions
- ►endojournals.org W Aldhahi, J Armstrong, C Bouche, RD Carr, … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Oral hypoglycemic agents bind to the ATP-sensitive potassium channel and lower
glucose levels effectively in individuals with diabetes. Although the principle
mechanism of action can also promote hypoglycemia, clinically profound ... Cited by 4 - Related articles - BL Direct - All 4 versions
